Evomedsp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2003-01-13
Share capital
1,610,000.00 PLN
Registered address
ul. Stanisława Dubois 27, 71-610 Szczecin, Poland
Electronic delivery address
AE:PL-99581-10365-HDEJD-29

Financials

Revenue history (in m)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 9 days for 2025). All were audited by a statutory auditor.

  • 202524/07/2026
  • 202401/07/2025
  • 202304/07/2024
  • 202217/07/2023
  • 202108/07/2022
  • 202009/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 18.17mMedianUSD 443.52kAverageUSD 1.75m
Net profit
This companyUSD 1.73mMedianUSD 14.31kAverageUSD 129.53k
Operating costs
This companyUSD 16.04mMedianUSD 397.10kAverageUSD 1.56m
Assets
This companyUSD 12.69mMedianUSD 173.92kAverageUSD 1.02m

Public procurement

3 tenders recorded as contractor: 2 national ($40,660) and 1 EU ($275,780).

SubjectAmount
Occupational health services provided to Poczta Polska S.A. in Szczecin
$275.8K
Provision of occupational health services for employees of Akademia Sztuki w Szczecinie.
$32,351
Provision of occupational health services for employees of Oddział Regionalny Agencji Mienia Wojskowego w Szczecinie
$8,309

National Health Fund (NFZ) contracts

Evomed has been an NFZ healthcare provider since 2008. In 2026 it is performing 11 contracts with a total value of USD 7.11m. All its contracts were worth USD 41.58m in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Outpatient specialist carezachodniopomorskie1USD 2.80m
Medical rehabilitationzachodniopomorskie1USD 2.19m
Outpatient specialist caremazowieckie1USD 955.92k
Nursing and care servicesmazowieckie1USD 369.10k
Psychiatric care and addiction treatmentmazowieckie2USD 352.94k

NFZ waiting lists

This company's facilities run 37 NFZ waiting lists. Waiting time forecast by NFZ, as of 13.10.2026.

ServiceWaiting time
Home physiotherapy2 days
Prosthodontics clinic3 days
Dental clinic5 days
Prosthetic treatment6 days
Otolaryngology services8 days

Trademarks

Evomed holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2016.

MarkNumberClassesStatusProtected until
EVOMED(word)Z.45203244Protected Feb 4, 2036
MarkProtected until
EVOMED(word)Feb 4, 2036

Authorized Representatives

Konrad Araszkiewicz – Vice President of the Management Board
Artur Robert Malejka – President of the Management Board
Radosław Krzysztof Dąbrowski – Vice President of the Management Board

Manner of representation

In the case of a multi-member management board: A) the President of the Management Board independently or each member of the management board acting independently is authorised to make declarations of will on behalf of the company and to perform by the company an act consisting in disposing of a right or incurring an obligation to provide a performance with a value not exceeding, in a single transaction or, in the case of continuous transactions, during one calendar year, PLN 300,000 (three hundred thousand zloty) (independent representation); B) above PLN 300,000, in a single transaction or, in the case of continuous transactions, during one year, joint action of the President of the Management Board jointly with a member of the management board, or joint action of two members of the management board, or a member of the management board jointly with a commercial proxy, is required to make declarations of will on behalf of the company and to perform by the company an act consisting in disposing of a right or incurring an obligation to provide a performance (joint representation). In the case of a one-person management board, the member of the management board is authorised to represent the company independently.

Supervisory board

Adam Krzysztof Roślewski – Supervisory Board Member
Anna Morcinek – Supervisory Board Member
Marzenna Dąbrowska Roślewska – Supervisory Board Member
Jakub Wozinski – Supervisory Board Member
Małgorzata Kosiewicz – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
Marzenna Dąbrowska Roślewskaage 65
1,545$208,670.9947.9814%
Adam Krzysztof Roślewski
1,630$220,151.2750.6211%
Others
45$6,077.801.3975%

Adam Krzysztof Roślewski and Marzenna Dąbrowska Roślewska hold a combined 98.6% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2000-12-01.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$880.3K
Buildings and premises
$5.5M

MSiG notices

Publication dateEvent
Dec 4, 2015Merger plan

Public aid

PurposeGross amount
Aid in the form of wage subsidies for the recruitment of workers with disabilities
$417

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Petra Medicasp. z o.o.
Telediagnosissp. z o.o.
Polmed Diagnostykasp. z o.o.
Zespół Przychodni Specjalistycznychsp. z o.o.
Noviasp. z o.o.
Centrum Medyczne Dąbrowa-Dąbrówkasp. z o.o.
Dolnośląskie Centrum Medyczne DolmedS.A.
Medika Usługi Medycznesp. z o.o.
Polvitasp. z o.o.
Estetic sp. z o.o.sp. k.

Change history

DateEvent
2016-09-27Address change
2016-09-27Name change
2016-06-30Share capital increase
2015-12-31PKD change
2009-10-27Switch to PKD 2007

FAQ

Last updated: 2026-07-24